Metraipolis › archive › dc_2e99190ac46e

DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH study — Europe PMC PMID:41800094

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41800094
DOI
10.3389/fphar.2026.1732128
License (as archived)
solo-consultazione
Archived
2026-11-05T14:53:38.984Z
SHA-256 of the archived text
99bd793eebf6ba6711e2d86efa78d5aa9fc3dd720178080f9740df331a0ff6b2
Stable URL of this page
https://metraipolis.com/documento/dc_2e99190ac46e

How to cite

DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH study — Europe PMC PMID:41800094 — Europe PMC (en), https://europepmc.org/article/MED/41800094 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2e99190ac46e (Metraipolis archive dc_2e99190ac46e, sha256 99bd793eebf6ba6711e2d86efa78d5aa9fc3dd720178080f9740df331a0ff6b2)
BibTeX
@misc{dc2e99190ac46e,
  title = {DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH study — Europe PMC PMID:41800094},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41800094},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2e99190ac46e; sha256 99bd793eebf6ba6711e2d86efa78d5aa9fc3dd720178080f9740df331a0ff6b2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41800094. Agents can read the archived copy with the MCP tool read_document.